Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 3
2021 5
2022 6
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S, Donadon M, Cipriani F, Fazio F, Ardito F, Iaria M, Perri P, Conci S, Dominioni T, Lai Q, La Barba G, Patauner S, Molfino S, Germani P, Zimmitti G, Pinotti E, Zanello M, Fumagalli L, Ferrari C, Romano M, Delvecchio A, Valsecchi MG, Antonucci A, Piscaglia F, Farinati F, Kawaguchi Y, Hasegawa K, Memeo R, Zanus G, Griseri G, Chiarelli M, Jovine E, Zago M, Abu Hilal M, Tarchi P, Baiocchi GL, Frena A, Ercolani G, Rossi M, Maestri M, Ruzzenente A, Grazi GL, Dalla Valle R, Romano F, Giuliante F, Ferrero A, Aldrighetti L, Bernasconi DP, Torzilli G; HE.RC.O.LE.S. Group. Famularo S, et al. JAMA Surg. 2023 Feb 1;158(2):192-202. doi: 10.1001/jamasurg.2022.6697. JAMA Surg. 2023. PMID: 36576813 Free PMC article.
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
Vitale A, Romano P, Cillo U; Writing Group for the HE.RC.O.LE.S Collaborative Group; Writing Group for the ITA.LI.CA Collaborative Group; HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups; Lauterio A, Sangiovanni A, Cabibbo G, Missale G, Marseglia M, Trevisani F, Foschi FG, Cipriani F, Famularo S, Marra F, Saitta C, Serenari M, Vidili G, Morisco F, Caturelli E, Mega A, Pelizzaro F, Nicolini D, Ardito F, Garancini M, Masotto A, Baroni GS, Azzaroli F, Giannini E, Perri P, Scarinci A, Fontana AP, Brunetto MR, Iaria M, Di Marco M, Nardone G, Dominioni T, Lai Q, Ferrari C, Rapaccini GL, Rodolfo S, Romano M, Conci S, Zoli M, Conticchio M, Zanello M, Zimmitti G, Fumagalli L, Troci A, Germani P, Gasbarrini A, La Barba G, De Angelis M, Patauner S, Molfino S, Zago M, Pinotti E, Frigo AC, Baiocchi GL, Frena A, Boccia L, Ercolani G, Tarchi P, Crespi M, Chiarelli M, Abu Hilal M, Cescon M, Memeo R, Ruzzenente A, Zanus G, Griseri G, Rossi M, Maestri M, Della Valle R, Ferrero A, Grazi GL, Romano F, Giuliante F, Vivarelli M, Jovine E, Torzilli G, Aldrighetti L, De Carlis L. Vitale A, et al. JAMA Surg. 2024 Aug 1;159(8):881-889. doi: 10.1001/jamasurg.2024.1184. JAMA Surg. 2024. PMID: 38771633
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario.
Famularo S, Cillo U, Lauterio A, Donadon M, Vitale A, Serenari M, Cipriani F, Fazio F, Giuffrida M, Ardito F, Dominioni T, Garancini M, Lai Q, Nicolini D, Molfino S, Perri P, Pinotti E, Conci S, Ferrari C, Zanello M, Patauner S, Zimmitti G, Germani P, Chiarelli M, Romano M, De Angelis M, La Barba G, Troci A, Ferraro V, Izzo F, Antonucci A, Belli A, Memeo R, Crespi M, Ercolani G, Boccia L, Zanus G, Tarchi P, Hilal MA, Frena A, Jovine E, Griseri G, Ruzzenente A, Zago M, Grazi G, Baiocchi GL, Vivarelli M, Rossi M, Romano F, Maestri M, Giuliante F, Valle RD, Ferrero A, Aldrighetti L, De Carlis L, Cescon M, Torzilli G; HE.RC.O.LE.S. Group Contributors. Famularo S, et al. HPB (Oxford). 2023 Oct;25(10):1223-1234. doi: 10.1016/j.hpb.2023.06.004. Epub 2023 Jun 12. HPB (Oxford). 2023. PMID: 37357112 Free article.
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysis.
Garancini M, Serenari M, Famularo S, Cipriani F, Ardito F, Russolillo N, Conci S, Nicolini D, Perri P, Zanello M, Iaria M, Lai Q, Romano M, La Barba G, Molfino S, Germani P, Dominioni T, Zimmiti G, Conticchio M, Fumagalli L, Zago M, Troci A, Sciannamea I, Ferrari C, Scotti MA, Griseri G, Antonucci A, Crespi M, Pinotti E, Chiarelli M, Memeo R, Hilal MA, Maestri M, Tarchi P, Baiocchi G, Ercolani G, Zanus G, Rossi M, Valle RD, Jovine E, Frena A, Patauner S, Grazi GL, Vivarelli M, Ruzzenente A, Ferrero A, Giuliante F, Aldrighetti L, Torzilli G, Cescon M, Bernasconi D, Romano F; HE.RC.O.LE.S. Group. Garancini M, et al. Langenbecks Arch Surg. 2024 Aug 11;409(1):248. doi: 10.1007/s00423-024-03419-4. Langenbecks Arch Surg. 2024. PMID: 39127855
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis.
Serenari M, Lenzi J, Cucchetti A, Cipriani F, Donadon M, Ardito F, Fazio F, Nicolini D, Iaria M, Famularo S, Perri P, Ansaloni L, Zanello M, Lai Q, Conci S, Molfino S, Ferrari C, Germani P, Zago M, Romano M, Zimmitti G, Antonucci A, Fumagalli L, Troci A, Ferraro V, Memeo R, Crespi M, Chiarelli M, Ercolani G, Hilal MA, Zanus G, Pinotti E, Tarchi P, Griseri G, Baiocchi GL, Ruzzenente A, Rossi M, Jovine E, Maestri M, Grazi GL, Romano F, Dalla Valle R, Ravaioli M, Vivarelli M, Ferrero A, Giuliante F, Torzilli G, Aldrighetti L, Cescon M; HE.RC.O.LE.S. Group. Serenari M, et al. Ann Surg. 2023 Apr 1;277(4):664-671. doi: 10.1097/SLA.0000000000005439. Epub 2022 Jun 29. Ann Surg. 2023. PMID: 35766422
Association of indirect measurement of cell function by bioimpedance analysis with complications in oncologic hepatic surgery.
Famularo S, Donadon M, Roccamatisi L, Di Lucca G, Angrisani M, Baccalini E, Franchi E, Corleone P, Garancini M, Sandini M, Braga M, Torzilli G, Gianotti L. Famularo S, et al. Among authors: corleone p. HPB (Oxford). 2023 Mar;25(3):283-292. doi: 10.1016/j.hpb.2022.09.008. Epub 2022 Oct 7. HPB (Oxford). 2023. PMID: 36702662 Free article.
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study.
Famularo S, Donadon M, Cipriani F, Ardito F, Iaria M, Carissimi F, Perri P, Dominioni T, Zanello M, Conci S, Molfino S, D'Acapito F, Germani P, Ferrari C, Patauner S, Pinotti E, Sciannamea I, Garatti M, Lodo E, Troci A, Delvecchio A, Floridi A, Bernasconi DP, Fumagalli L, Chiarelli M, Memeo R, Crespi M, Zanus G, Zimmitti G, Antonucci A, Zago M, Frena A, Griseri G, Tarchi P, Ercolani G, Baiocchi GL, Ruzzenente A, Jovine E, Maestri M, Grazi G, Valle RD, Giuliante F, Aldrighetti L, Romano F, Torzilli G; HE.RC.O.LE.S. Group. Famularo S, et al. J Gastrointest Surg. 2021 Nov;25(11):2823-2834. doi: 10.1007/s11605-021-04952-z. Epub 2021 Mar 9. J Gastrointest Surg. 2021. PMID: 33751404
18 results